Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Cogent Biosciences, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 195 | 2 | 267 | +74 |
| Shares | 159.2M | 264.6K | 174.1M | +15.1M (+9.5%) |
| Value | $2.29B | $3.80M | $6.18B | +$3.90B (+170.9%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (95)
Institutions that held Cogent Biosciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (21)
Institutions that held Cogent Biosciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Paradigm Biocapital Advisors LP | 3,156,398 | $45.3M |
| Boone Capital Management LLC | 945,042 | $13.6M |
| Logos Global Management LP | 500,000 | $7.18M |
| Macquarie Group Ltd | 398,830 | $5.73M |
| Jacobs Levy Equity Management, Inc | 187,083 | $2.69M |
| Caption Management, LLC | 176,064 | $2.53M |
| Jane Street Group, LLC | 148,401 | $2.13M |
| Acuta Capital Partners, LLC | 102,907 | $1.48M |
| Simplex Trading, LLC | 66,988 | $961.0K |
| Group One Trading, L.P. | 50,505 | $725.3K |
| Readystate Asset Management LP | 49,692 | $713.6K |
| Panagora Asset Management Inc | 44,042 | $632.4K |
| Quadrature Capital Ltd | 40,475 | $580.8K |
| XTX Topco Ltd | 37,831 | $543.3K |
| Capstone Investment Advisors, LLC | 20,120 | $288.9K |
| LGL Partners, LLC | 14,500 | $208.2K |
| Ikarian Capital, LLC | 11,280 | $162.0K |
| SkyView Investment Advisors, LLC | 10,133 | $146.0K |
| Crowley Wealth Management, Inc. | 1,700 | $24.4K |
| Bessemer Group Inc | 86 | $1.00K |
| FNY Investment Advisers, LLC | 14 | $0 |
Not filed for Q4 2025 yet (2)
Institutions that held Cogent Biosciences, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| New Leaf Venture Partners, L.L.C. | 250,765 | $3.60M |
| CIBC Bancorp USA Inc. | 13,857 | $199.0K |